<DOC>
	<DOCNO>NCT02559128</DOCNO>
	<brief_summary>The purpose cross-sectional comparative 2x2 trial study compare degree insulin resistance , myocardial function select metabolic parameter explore pathophysiological mechanism insulin resistance implicate development chronic heart failure ( HF ) patient type 2 diabetes prediabetes ( T2D ) . Investigators hypothesize patient heart failure insulin-resistant display metabolic abnormality patient diabetes .</brief_summary>
	<brief_title>The Role Insulin Resistance Patients With Heart Failure Type 2 Diabetes</brief_title>
	<detailed_description>100 subject total , divide four group include : 40 patient type 2 diabetes prediabetes chronic HF without previous pharmacological treatment ( T2D+HF+ ) , 20 subject HF without T2D ( HF+T2D- ) , 20 subject T2D alone ( HF-T2D+ ) 20 healthy control volunteer ( HF-T2D- ) . All examination do short admission Diabetes Center ( CD ) Institute Clinical Experimental Medicine ( IKEM ) , always comparable circumstance . All participant undergo standardize selection metabolic cardiovascular test . Oxidative stress marker , select cytokine , peptide metabolite blood subcutaneous adipose tissue analyze . Investigators assume project bring new knowledge contribute discovery mechanisms implicate development heart failure patient type 2 diabetes .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>A . For group HF+T2D+ 1 . Chronic heart failure define follow criterion ( must include ) : diagnosis HF know least 6 month medical history hospitalization cardiac decompensation need parenteral therapy congestion Xray finding swell low extremity stable drug therapy least 1 month treatment diuretic ( thiazide furosemide ) leave ventricular ejection fraction ( LVEF ) 50 % 2 . The presence diabetes/prediabetes define : diagnosis treatment type 2 diabetes medical history estimate screen blood sample : value HbA1c ( accord IFCC ) ≥39 mmol/mol prediabetes , ≥48 diabetes fast plasma glucose level ≥5.6 mmol/l prediabetes ≥7 mmol/l diabetes ≥7.8 mmol/l prediabetes ≥11.1 mmol/l diabetes accord oral glucose tolerance test ( oGTT ) . treatment diabetes diet woman men age 4070 year body mass index ( kg/m2 ) range 2035 range HbA1c 4065 mmol/mol ( IFCC ) sign informed consent B.For group HF+T2D Chronic heart failure define follow criterion ( must include ) : diagnosis HF know least 6 month medical history hospitalization cardiac decompensation need parenteral therapy congestion Xray finding swell low extremity stable drug therapy least 1 month treatment diuretic ( thiazide furosemide ) LVEF 50 % history diabetes , HbA1c &lt; 39 mmol/mol ( IFCC ) fast plasma glucose level 5.6 mmol/l woman men age 4070 year body mass index ( kg/m2 ) range 2035 sign inform consent C.For group HFT2D+ The presence diabetes/prediabetes define : diagnosis treatment type 2 diabetes medical history estimate screen blood sample : value HbA1c ( accord IFCC ) ≥39 mmol/mol prediabetes , ≥48 diabetes fast plasma glucose level ≥5.6 mmol/l prediabetes ≥7 mmol/l diabetes ≥7.8 mmol/l prediabetes ≥11.1 mmol/l diabetes accord oGTT treatment diabetes diet woman men age 4070 year body mass index ( kg/m2 ) range 2035 range HbA1c 4065 mmol/mol ( IFCC ) history acute chronic heart disease sign informed consent D.For group HFT2D Absence metabolic syndrome ( two follow symptom ) : abdominal obesity waist circumference men &gt; 102 cm , woman &gt; 88 cm diagnosis treatment type 2 diabetes raise fast plasma glucose level ( FPG &gt; 5,6 mmol/l ) raise blood pressure ( BP ) : systolic BP &gt; 130 mm Hg diastolic BP &gt; 85 mm Hg , treatment previously diagnose hypertension reduce HDL cholesterol men &lt; 1 mmol/l , woman &lt; 1,3 mmol/l ( treatment ) raise triglyceride &gt; 1,7 mmol/l ( treatment ) absence chronic acute cardiovascular disease woman men age 4070 year body mass index ( kg/m2 ) range 2035 sign inform consent Exclusion Criteria group ( A+B+C+D ) : metabolic disease , include : 1 type diabetes , decompensated thyreopathy ( Note : patient hypothyroidism stable substitution ( last 3 month ) normal thyrotropicstimulating hormone level may participate study ) pregnancy ( positive human chorionic gonadotropin test ) , breast feeding , try become pregnant clinically significant anemia hemoglobin 100 g/l renal insufficiency estimate glomerular filtration 0.7 ml/s atrial fibrillation alcoholism drug use presence medical condition , occur physical examination , laboratory test , ECG , include pulmonary , neurological inflammatory disease , would consider examiner distort consistency data</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Insulin Resistance</keyword>
	<keyword>Chronic Heart Failure</keyword>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Endothelial Dysfunction</keyword>
</DOC>